Patent · US Active

Compositions and methods related to recombinant antibodies to histone posttranslational modifications

US10208110B2 · kind B2 · utility

0Cited by
0References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 27, 2014
Grant dateFeb 19, 2019
Priority date
Expiry dateFeb 18, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/50
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Embodiments concern compositions and methods involving recombinant antibodies to histone post-translational modifications. The invention provides compositions and methods for histone methyltransferase assays. In certain embodiments, the compositions and methods involve a recombinant antibody that binds histone H3 fragment harboring biomarkers such as H3K9me3 mark, H3K4me3 mark, H3K36me3 mark, H3K27me3, H3K9me3 and H3S10phos or a recombinant antibody that binds histone H4 fragment harboring H4K20me3 mark.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.